Insider · CIK 0001263500
CZEREPAK ELIZABETH
Reports to the SEC for 9 companies · QUEENSBURY, NY
Transactions
23
Companies
9
Filings
16
CIK
0001263500
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-05-13 | DCTHDELCATH SYSTEMS, INC. · Stock Option (right to buy)A Award | — |
| 2025-05-15 | DCTHDELCATH SYSTEMS, INC. · Stock Option (right to buy)A Award | — |
| 2024-05-23 | DCTHDELCATH SYSTEMS, INC. · Stock Option (right to buy)A Award | — |
| 2023-06-12 | DCTHDELCATH SYSTEMS, INC. · Stock Option (Right to Buy)A Award | — |
| 2023-01-17 | SCLXScilex Holding Co · Nonstatutory Stock Option (right to buy)A Award | — |
| 2022-05-18 | Sorrento Therapeutics, Inc.Stock Option (right to buy)A Award | — |
| 2022-05-04 | DCTHDELCATH SYSTEMS, INC. · Stock OptionsA Award | — |
| 2021-11-18 | Sorrento Therapeutics, Inc.Stock Option (right to buy)A Award | — |
| 2021-08-05 | DCTHDELCATH SYSTEMS, INC. · Stock Option (right to buy)A Award | — |
| 2020-11-23 | DCTHDELCATH SYSTEMS, INC. · Stock Option (right to buy)A Award | — |
| 2020-06-18 | SPECTRUM PHARMACEUTICALS INCA Award | — |
| 2020-06-18 | SPECTRUM PHARMACEUTICALS INCStock Option (Right to Buy)A Award | — |
| 2019-06-20 | SPECTRUM PHARMACEUTICALS INCA Award | — |
| 2019-06-20 | SPECTRUM PHARMACEUTICALS INCStock Option (Right to Buy)A Award | — |
| 2017-09-22 | ALTAltimmune, Inc. · Stock Options (option to buy)A Award | — |
| 2017-09-22 | ALTAltimmune, Inc. · Stock Options (option to buy)A Award | — |
| 2017-05-04 | ALTAltimmune, Inc. · Stock Option (option to buy)A Award | — |
| 2017-05-04 | ALTAltimmune, Inc. · Stock Option (option to buy)A Award | — |
| 2007-05-31 | AFFYMAX INCStock Option (Right to Buy)A Award | — |
| 2005-05-25 | MiddleBrook Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award | — |
| 2003-10-22 | MiddleBrook Pharmaceuticals, Inc.Series E Convertible Preferred StockC Conversion | — |
| 2003-10-22 | MiddleBrook Pharmaceuticals, Inc.C Conversion | — |
| 2003-10-16 | MiddleBrook Pharmaceuticals, Inc.Stock Option (right to buy)A Award | — |
Recent filings
- 4CZEREPAK ELIZABETH0001263500-26-000004SEC(opens sec.gov)
- 4CZEREPAK ELIZABETH0001415889-25-013614SEC(opens sec.gov)
- 4CZEREPAK ELIZABETH0001415889-24-014678SEC(opens sec.gov)
- 4CZEREPAK ELIZABETH0000899243-23-016196SEC(opens sec.gov)
- 4CZEREPAK ELIZABETH0000899243-23-001870SEC(opens sec.gov)
- 4CZEREPAK ELIZABETH0001209191-22-031081SEC(opens sec.gov)
- 4CZEREPAK ELIZABETH0000899243-22-017041SEC(opens sec.gov)
- 4CZEREPAK ELIZABETH0001209191-21-065539SEC(opens sec.gov)
- 4CZEREPAK ELIZABETH0000899243-21-032163SEC(opens sec.gov)
- 4CZEREPAK ELIZABETH0000899243-20-032201SEC(opens sec.gov)
- 4CZEREPAK ELIZABETH0001209191-20-037982SEC(opens sec.gov)
- 4CZEREPAK ELIZABETH0001209191-19-040441SEC(opens sec.gov)
- 4CZEREPAK ELIZABETH0001012975-17-000719SEC(opens sec.gov)
- 4Altimmune, Inc.0000899243-17-012356SEC(opens sec.gov)
- 4AFFYMAX INC0001179110-07-011839SEC(opens sec.gov)
- 4ADVANCIS PHARMACEUTICAL CORP0001209191-05-028395SEC(opens sec.gov)
Companies
- AFFYMAX INCDirector, 10% Owner
- Altimmune, Inc.CFO and EVP Corp. DevelopmentALT
- DELCATH SYSTEMS, INC.DirectorDCTH
- MiddleBrook Pharmaceuticals, Inc.Director
- Scilex Holding CoSee RemarksSCLX
- Sorrento Therapeutics, Inc.EVP & Chief Financial Officer
- SPECTRUM PHARMACEUTICALS INCDirector
- Transcode Therapeutics, Inc.DirectorRNAZ
- Vyant Bio, Inc.Chief Financial Officer
Address
C/O DELCATH SYSTEMS, INC., 566 QUEENSBURY AVENUE
QUEENSBURY, NY, 12804